Tag: UK MHRA
Cidara Therapeutics’ REZZAYO bags UK and EU approvals in invasive candidiasis
Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company focused on developing life-saving therapies, announced a significant breakthrough with the United Kingdom (U.K.) Medicines and Healthcare ... Read More
Mirati Therapeutics secures UK approval for KRAZATI in advanced NSCLC
Mirati Therapeutics, Inc. (NASDAQ: MRTX), an innovative biotechnology company, has received conditional authorization from the UK's Medicines and Healthcare Products Regulatory Agency (MHRA) for its ... Read More
Alkem Labs clears UK MHRA inspection of bioequivalence center in Taloja
Alkem Laboratories Limited (Alkem Labs) revealed that it has cleared an online inspection held by the UK Medicines and Healthcare products Regulatory Agency (MHRA) of ... Read More
AstraZeneca gets UK MHRA approval for Evusheld for Covid-19 prevention
AstraZeneca said that its antibody combination Evusheld (tixagevimab co-packaged with cilgavimab) has been authorized by the UK Medicines and Healthcare products Regulatory Agency (MHRA) for ... Read More
Marksans Pharma gets approval for Loperamide 2mg hard capsules in UK
Marksans Pharma Limited said that its fully-owned subsidiary Relonchem Limited has secured market authorization from the UK Medicines and Healthcare products Regulatory Agency (MHRA) for ... Read More
FDC Limited gets GMP certificate for ophthalmic facility from UK MHRA
FDC Limited said that it has secured Good Manufacturing Practice (GMP) certificate for its ophthalmic facility in Aurangabad, Maharashtra from the UK Medicines and Healthcare ... Read More
Indoco Remedies’ AnaCipher CRO gets UK MHRA’s accreditation
Indoco Remedies said that it has secured GCP and GLP accreditation from the UK’s Medicines and Healthcare Products Regulatory Agency (MHRA) for AnaCipher, the company’s ... Read More
UK authorizes Pfizer and BioNTech’s BNT162b2 Covid-19 vaccine
The UK has given a temporary authorization for emergency use for the BNT162b2 Covid-19 vaccine candidate developed by Pfizer and BioNTech. The emergency use authorization ... Read More